ARCHIVES

NCI plans to cut staff access to The Cancer Letter; insiders allege attempt at “thought control.”

This article is from The Cancer Letter archive.

Vol. 31 No. 42 | November 18, 2005

Download PDF Visit The Full Archive

Related Articles

Phase III Alimta Trial Fails To Extend Progression-Free Survival Without Grade 4 Adverse Events

June 28, 2013

Interim Funding: Noncompeting Renewals Reduced By 4 Percent, Competing Current Plus 7 Percent

January 8, 1982

Construction Report Scheduled for NCAB

August 25, 1978

DePinho’s Wife Was Briefed on AVEO Data 11 Days Before He Touted Stock on CNBC

September 13, 2013

Letter to the Editor: Could Managed care Cause Drop In Accrual In Suramin Trial?

January 5, 1996

Phase III Study: Rituxan Improved PFS By 79% In Advanced Follicular Lymphoma

December 31, 2010